Grupo Financiero Galicia S.A. (GGAL)
Buenos Aires Exchange · Argentina · prices in ARS · close of 22 Oct 2026
Key indicators
| Last close | ARS 5,900.00 |
|---|---|
| 52-week range | 5,000.00 – 9,395.00 |
| Return, 1 month / 3 months | −11.1% / −28.7% |
| Return, 1 year / 3 years | +11.2% / +410.3% |
| Trend | Below its 200-day average |
| RSI (14) | 41 |
| Volatility (1 year) | 44.1% |
| Worst drawdown (1 year) | -37.9% |
| Average daily value traded | 15,878.11M ARS |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Grupo Financiero Galicia is an Argentine financial services holding company based in Buenos Aires. Through its main bank subsidiary, Banco Galicia, it offers retail and corporate banking, including deposits, loans, credit cards and payment services, to individuals and businesses across the country. The group also provides insurance and other financial products through affiliated companies, serving customers in Argentina's domestic market.
The shares are listed on the Buenos Aires Exchange in Argentina under the code GGAL, and the price on this page is in Argentine pesos (ARS). Our dividend records, which start in 2019, show payments in 4 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Grupo Financiero Galicia S.A. (GGAL) trades on the Buenos Aires Exchange in Argentina. It last closed at ARS 5,900.00 on 22 October 2026.
Its price-based Market X-Ray is 42 out of 100 (a weak price profile), ranking 102 of 154 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 11.2% and over the last three months it fell 28.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Buenos Aires Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 25 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -16.5% | ||
| From 52-week high | -35.8% | ||
| Momentum | 31 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -28.7% | ||
| 6-month return | -13.4% | ||
| 12-month return, skipping the last month | 25.2% | ||
| Stability (higher is calmer) | 37 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 44.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -37.9% | ||
| Liquidity | 100 · Strong | Trades actively. | |
| Average daily value traded | 15,878.11M ARS | ||
| Zero-volume days | 1.7% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 1 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | +0.0% |
|---|---|
| 1 month | −11.1% |
| 3 months | −28.7% |
| 6 months | −13.4% |
| 1 year | +11.2% |
| 3 years | +410.3% |
| 5 years | +2,477.5% |
Signals
| 50-day / 200-day average | 6,505.86 / 7,066.53 |
|---|---|
| Golden / death cross (60 days) | Death, 22 days ago |
| New 52-week high | No |
| Bullish RSI divergence | Yes |
| Average daily range (ATR) | 230.83 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 5 May 2022 | ARS 7.4592 |
| 6 May 2021 | ARS 1.0172 |
| 1 Oct 2020 | ARS 1.1915 |
| 7 May 2019 | ARS 1.4018 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Buenos Aires Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.